Security key
04280A100
ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)
CUSIP: 04280A100
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 97,715,477
- Total 13F value
- $1,892,897,060
- Share change
- -2,696,313
- Put/Call ratio
- 278%
- SEC-reported price per share
- $19.37
- Number of holders
- 267
- Value change
- -$93,908,485
- Number of buys
- 117
- Number of sells
- 123
- Shares outstanding
- 141,328,976
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q3 2024
Institutions
267
Top holders
10
ARWR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
ARROWHEAD PHARMACEUTICALS, INC. SEC filings
ARROWHEAD PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04280A100
Recent filing periods:
Ownership snapshot
Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock Finance, Inc.
11%
VANGUARD GROUP INC
8.6%
Avoro Capital Advisors LLC
6.3%
FMR LLC
4.8%
STATE STREET CORP
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
11%
|
$407,606,524
15,683,206 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
8.6%
|
$317,444,486
12,214,101 shares
|
— | 30 Jun 2024 |
| Avoro Capital Advisors LLC |
13F
Company
|
6.3%
|
$231,022,199
8,888,888 shares
|
— | 30 Jun 2024 |
| FMR LLC |
13F
Company
|
4.8%
|
$177,049,933
6,812,233 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
4.1%
|
$151,723,434
5,837,762 shares
|
— | 30 Jun 2024 |
| Slate Path Capital LP |
13F
Company
|
2.9%
|
$107,572,610
4,139,000 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
267
Shares
97,715,477
Rows available
267
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
272
Q3 2024 holders
267
Holder diff
-5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend